Bringing the fundamentals into focus…
Back to LeMaitre Vascular, Inc.
How LeMaitre Vascular, Inc. stacks up
LMAT · against 384 other Healthcare companies of similar size
Growth
74/ 100
Above the middle of the pack.
Ranked #100 of 385 · scores higher than 73% of peers
Bars: peers in each 10-point band of the growth score36 peers with a growth score of 70–79, including LMAT · Click a bar to see the companies
Why growth scores 74?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth, earnings per share growth and revenue growth, which are stronger than most Healthcare peers.
- faster revenue growth over the last year: stronger than 65% of peers. Revenue growth: 11.8% vs peer median 6.1%
- faster growth in earnings per share: stronger than 73% of peers. Earnings per share growth: 38.0% vs peer median 9.8%
- faster revenue growth over three years: stronger than 84% of peers. 3-year revenue growth: 23.8% vs peer median 5.8%
Metric by metric
Position: dot = LMAT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | LMAT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 387 reported | 11.8% | 6.2% | 64% | 33% | |
| Earnings per share growthHigher is better · 218 reported | 38.0% | 8.3% | 76% | 33% | |
| 3-year revenue growthHigher is better · 377 reported | 23.8% | 7.2% | 82% | 33% |
Ranking by growth score
Top 5 and the companies ranked around LMAT| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 95 | 2.2B USD | 75 | 78 | |
| 100 | 1.62T KRW (≈$1.2B) | 74 | 50 | |
| 100 | 7.0B SAR (≈$1.9B) | 74 | 56 | |
| 100 | 18.3B DKK (≈$2.7B) | 74 | 81 | |
| 100 | 1.8B USD | 74 | 79 | |
| 104 | 10.2B CNY (≈$1.4B) | 73 | 71 | |
| 104 | 212.3B JPY (≈$1.4B) | 73 | 62 | |
| 104 | 23.2B CNY (≈$3.2B) | 73 | 62 | |
| 104 | 73.5B TRY (≈$2.2B) | 73 | 68 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score